InvestorsHub Logo
Followers 185
Posts 12470
Boards Moderated 0
Alias Born 10/09/2012

Re: hen81 post# 54451

Friday, 02/21/2014 1:02:47 PM

Friday, February 21, 2014 1:02:47 PM

Post# of 91007
Yes, very happy to see research of cardiac disorders treated with stem cells...am anticipating Dr. Khalpey's results with Intellicell's product!

Quote: "I believe that with the use of cavitation technology to harvest the stromal vascular fraction from a lipoaspirate without chemicals and enzymes, we would be able to capture the appropriate stem cells with their micromatrix and microenvironment for use in patients with failing hearts and lungs."

In his research role at the UA, he is the director of the Ex Vivo Lung Program, clinical and translational research, and the Cardiopulmonary Stem Cell Bank. Dr. Khalpey also holds a position on the UA Institutional Review Board (IRB).

He also is involved in creating clinical “bridge-to-regeneration” trials, in which autologous stem cells will be injected into failing hearts with the hope of recovery in an era of limited hearts for transplantation.

http://marketwatch.com/story/intellicell-biosciences-announces-that-dr-zain-khalpey-has-joined-its-advisory-board-2013-06-17

http://opa.ahsc.arizona.edu/newsroom/news/2013/heart-surgeon-zain-khalpey-appointed-lead-heart-transplant-program-mechanical-cir

GO SVFC $$$$

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.